119 related articles for article (PubMed ID: 10650785)
1. Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy.
Savas B; Arslan G; Gelen T; Karpuzoglu G; Ozkaynak C
Anticancer Res; 1999; 19(5C):4413-20. PubMed ID: 10650785
[TBL] [Abstract][Full Text] [Related]
2. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma.
Zukauskaite R; Schmidt H; Asmussen JT; Hansen O; Bastholt L
Melanoma Res; 2013 Feb; 23(1):21-6. PubMed ID: 23117880
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
Garbe C
Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignant melanoma: recent advances and perspectives].
Saida T
Gan To Kagaku Ryoho; 1997 Jan; 24(1):10-5. PubMed ID: 9020939
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
7. Primary malignant melanoma of the pharynx.
Oztürk O; Ozek H; Cansiz H; Karakullukçu B
J Laryngol Otol; 2001 Nov; 115(11):931-4. PubMed ID: 11779316
[TBL] [Abstract][Full Text] [Related]
8. Bolus high dose interleukin-2 for the treatment of malignant melanoma.
Pappo I; Lotem M; Klein M; Orda R
Isr Med Assoc J; 2001 Mar; 3(3):169-73. PubMed ID: 11303372
[TBL] [Abstract][Full Text] [Related]
9. Our experience with interferon alpha: metastatic malignant melanoma.
Merimsky O; Chaitchik S
Mol Biother; 1992 Sep; 4(3):135-8. PubMed ID: 1445667
[TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA
Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431
[TBL] [Abstract][Full Text] [Related]
11. [Multiple melanoma metastasis. Case report].
Adam D
Chirurgia (Bucur); 2010; 105(4):563-9. PubMed ID: 20941984
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for brain metastases from melanoma.
McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
[TBL] [Abstract][Full Text] [Related]
13. Multiple intracranial melanoma metastases: case report and review of the literature.
Guzel A; Maciaczyk J; Dohmen-Scheufler H; Senturk S; Volk B; Ostertag CB; Nikkhah G
J Neurooncol; 2009 Jul; 93(3):413-20. PubMed ID: 19184642
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report.
Möller P; Wittig B; Schadendorf D
Anticancer Res; 1998; 18(2B):1237-41. PubMed ID: 9615794
[TBL] [Abstract][Full Text] [Related]
15. Miliary brain metastases from malignant melanoma.
Rainov NG; Burkert W
Zentralbl Neurochir; 1996; 57(1):20-4. PubMed ID: 8900895
[TBL] [Abstract][Full Text] [Related]
16. Multiple intracranial metastases of malignant melanoma with long-term survival. Case report.
Fernandez E; Maira G; Puca A; Vignati A
J Neurosurg; 1984 Mar; 60(3):621-4. PubMed ID: 6699709
[TBL] [Abstract][Full Text] [Related]
17. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE
Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362
[TBL] [Abstract][Full Text] [Related]
18. Response of recurrent brain metastases in malignant melanoma to 5-fluorouracil and interferon-alpha therapy.
Phuphanich S; Jacobs M; Spiers A
J Neuroimaging; 1994 Apr; 4(2):114-6. PubMed ID: 8186529
[TBL] [Abstract][Full Text] [Related]
19. [A case of recurrent malignant melanoma of esophagus responsive to combined chemotherapy, radiotherapy and cellular immunotherapy].
Motoyama S; Maruyama K; Sato Y; Shibuya K; Usami S; Yoshino K; Nakatsu T; Nanjo H; Kamata S; Ogawa J
Gan To Kagaku Ryoho; 2011 Apr; 38(4):639-42. PubMed ID: 21498995
[TBL] [Abstract][Full Text] [Related]
20. [Systemic therapy of metastatic malignant melanoma].
Stahel RA; Martz G
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):459-62. PubMed ID: 3259710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
